190 related articles for article (PubMed ID: 8557981)
21. Use of JH4 joining segment gene by an anti-arsonate antibody that bears the major A-strain cross-reactive idiotype but displays diminished antigen binding.
Slaughter CA; Jeske DJ; Kuziel WA; Milner EC; Capra JD
J Immunol; 1984 Jun; 132(6):3164-71. PubMed ID: 6427333
[TBL] [Abstract][Full Text] [Related]
22. Predicting regional mutability in antibody V genes based solely on di- and trinucleotide sequence composition.
Shapiro GS; Aviszus K; Ikle D; Wysocki LJ
J Immunol; 1999 Jul; 163(1):259-68. PubMed ID: 10384124
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of the cross-reactive idiotype of the A strain mouse.
Hasemann CA; Capra JD
J Immunol; 1991 Nov; 147(9):3170-9. PubMed ID: 1717589
[TBL] [Abstract][Full Text] [Related]
24. Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus.
Zhang M; Zharikova D; Mozdzanowska K; Otvos L; Gerhard W
Mol Immunol; 2006 Jul; 43(14):2195-206. PubMed ID: 16472860
[TBL] [Abstract][Full Text] [Related]
25. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
Lazdina U; Cao T; Steinbergs J; Alheim M; Pumpens P; Peterson DL; Milich DR; Leroux-Roels G; Sällberg M
J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303
[TBL] [Abstract][Full Text] [Related]
26. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
27. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
28. Structural correlates of an anticarcinoma antibody: identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only.
Tamura M; Milenic DE; Iwahashi M; Padlan E; Schlom J; Kashmiri SV
J Immunol; 2000 Feb; 164(3):1432-41. PubMed ID: 10640759
[TBL] [Abstract][Full Text] [Related]
29. Arginine mutation alters binding of a human monoclonal antibody to antigens linked to systemic lupus erythematosus and the antiphospholipid syndrome.
Lambrianides A; Giles I; Ioannou Y; Mason L; Latchman DS; Manson JJ; Isenberg DA; Rahman A
Arthritis Rheum; 2007 Jul; 56(7):2392-401. PubMed ID: 17599767
[TBL] [Abstract][Full Text] [Related]
30. The invariant tryptophan in an H chain V region is not essential to antibody binding.
Sharon J
J Immunol; 1988 Apr; 140(8):2666-9. PubMed ID: 3128602
[TBL] [Abstract][Full Text] [Related]
31. Use of phage surface expression to analyze regions of human V4-34(VH4-21)-encoded IgG autoantibody required for recognition of DNA: no involvement of the 9G4 idiotope.
Mockridge CI; Chapman CJ; Spellerberg MB; Isenberg DA; Stevenson FK
J Immunol; 1996 Sep; 157(6):2449-54. PubMed ID: 8805644
[TBL] [Abstract][Full Text] [Related]
32. Primary sequence and location of the idiotopes of V-88, a DNA-binding monoclonal autoantibody, determined by idiotope scanning with synthetic peptides on pins.
Staines NA; Ward FJ; Denbury AN; Mitchiner J; Hartley O; Eilat D; Isenberg DA; Bansal S
Immunology; 1993 Mar; 78(3):371-8. PubMed ID: 7682987
[TBL] [Abstract][Full Text] [Related]
33. Structural consequences of humanizing an antibody.
Holmes MA; Foote J
J Immunol; 1997 Mar; 158(5):2192-201. PubMed ID: 9036965
[TBL] [Abstract][Full Text] [Related]
34. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
Pruett PS; Air GM
Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
[TBL] [Abstract][Full Text] [Related]
36. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
37. Peptidomimics of antigen are present in variable region of heavy and light chains of anti-idiotypic antibody and function as surrogate antigen for perpetuation of immunological memory.
Vani J; Justin J; Nagasuma RC; Nayak R; Shaila MS
Mol Immunol; 2007 Jul; 44(13):3345-54. PubMed ID: 17408744
[TBL] [Abstract][Full Text] [Related]
38. Replacing the complementarity-determining regions in a human antibody with those from a mouse.
Jones PT; Dear PH; Foote J; Neuberger MS; Winter G
Nature; 1986 May 29-Jun 4; 321(6069):522-5. PubMed ID: 3713831
[TBL] [Abstract][Full Text] [Related]
39. Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity.
Cacia J; Keck R; Presta LG; Frenz J
Biochemistry; 1996 Feb; 35(6):1897-903. PubMed ID: 8639672
[TBL] [Abstract][Full Text] [Related]
40. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
